Cite
Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129.
MLA
Badimon, Lina, et al. “Cardiovascular RNA Markers and Artificial Intelligence May Improve COVID-19 Outcome: A Position Paper from the EU-CardioRNA COST Action CA17129.” Cardiovascular Research, vol. 117, no. 8, July 2021, pp. 1823–40. EBSCOhost, https://doi.org/10.1093/cvr/cvab094.
APA
Badimon, L., Robinson, E. L., Jusic, A., Carpusca, I., deWindt, L. J., Emanueli, C., Ferdinandy, P., Gu, W., Gyöngyösi, M., Hackl, M., Karaduzovic-Hadziabdic, K., Lustrek, M., Martelli, F., Nham, E., Potočnjak, I., Satagopam, V., Schneider, R., Thum, T., & Devaux, Y. (2021). Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. Cardiovascular Research, 117(8), 1823–1840. https://doi.org/10.1093/cvr/cvab094
Chicago
Badimon, Lina, Emma L Robinson, Amela Jusic, Irina Carpusca, Leon J deWindt, Costanza Emanueli, Péter Ferdinandy, et al. 2021. “Cardiovascular RNA Markers and Artificial Intelligence May Improve COVID-19 Outcome: A Position Paper from the EU-CardioRNA COST Action CA17129.” Cardiovascular Research 117 (8): 1823–40. doi:10.1093/cvr/cvab094.